Question to the Department of Health and Social Care:

To ask His Majesty's Government what steps they are taking to ensure that advanced therapy medicinal product clinical trials in the United Kingdom reflect the diversity of patient populations who might benefit from those treatments.

It has not proved possible to respond to this question in the time available before Prorogation. Ministers will correspond directly with the Member.